N
AVTX icon

Nuveen’s Avalo Therapeutics AVTX Stock Holding History

Nuveen’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-141
Closed -$294K – 3254
2022
Q1 		$294K Sell
141
-65
-32% -$163K ﹤0.01% 3126
2021
Q4 		$1.01M Sell
206
-6
-3% -$36K ﹤0.01% 2860
2021
Q3 		$1.37M Buy
212
+92
+77% +$746K ﹤0.01% 2847
2021
Q2 		$1.13M Buy
120
+33
+38% +$276K ﹤0.01% 2965
2021
Q1 		$758K Buy
87
+27
+45% +$255K ﹤0.01% 2984
2020
Q4 		$457K Buy
60
+1
+2% +$6.95K ﹤0.01% 3059
2020
Q3 		$389K Buy
59
+5
+9% +$37.6K ﹤0.01% 3019
2020
Q2 		$402K Buy
54
+29
+116% +$211K ﹤0.01% 2974
2020
Q1 		$176K Buy
25
+5
+25% +$52.9K ﹤0.01% 3013
2019
Q4 		$310K Hold
20
– – ﹤0.01% 3001
2019
Q3 		$190K Hold
20
– – ﹤0.01% 3126
2019
Q2 		$313K Buy
+20
New +$303K ﹤0.01% 3114

Other funds holding AVTX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return